Neuron navigator 1 inhibitors belong to a distinct chemical class that has garnered significant attention in scientific research. These inhibitors are characterized by their ability to modulate the activity of neuron navigator 1 (NAV1), a protein involved in neuronal development and axonal guidance. Neuron navigator 1 is critical for proper neuronal growth and migration during embryonic development, as well as for the establishment of neural circuits in the central nervous system. The inhibitors work by selectively binding to the active site of neuron navigator 1, interfering with its normal function. By doing so, they exert a regulatory influence on the intricate processes that govern neuronal navigation and guidance. This modulation of neuron navigator 1 activity can potentially impact the formation and connectivity of neural networks, which are vital for the proper functioning of the nervous system. Chemically, neuron navigator 1 inhibitors exhibit a diverse range of structural features, reflecting the extensive efforts undertaken in medicinal chemistry to design molecules with high affinity and selectivity for the target protein. These inhibitors often possess specific functional groups and spatial arrangements that enable them to interact with key residues within the active site of neuron navigator 1, thus impeding its normal enzymatic activity.
Research studies investigating neuron navigator 1 inhibitors have primarily focused on elucidating their molecular mechanisms of action and exploring their effects on neuronal development in various experimental models. These inhibitors have shown promise in influencing axonal outgrowth, neuronal migration, and the establishment of neuronal connectivity during early developmental stages. The exploration of neuron navigator 1 inhibitors is an ongoing endeavor, with scientists aiming to uncover more about their precise mechanisms and further optimize their chemical structures to enhance potency, selectivity, and pharmacokinetic properties. Continued research in this field holds the potential to deepen our understanding of neuronal development and contribute to future advancements in neuroscience and related disciplines.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-803467 | 944261-79-4 | sc-201068 sc-201068B sc-201068A | 10 mg 25 mg 50 mg | $89.00 $188.00 $349.00 | 1 | |
A potent and selective Nav1.8 inhibitor, A-803467 demonstrates strong analgesic properties in research studies. It selectively targets Nav1.8 channels, which are primarily expressed in sensory neurons involved in pain transmission. | ||||||
Carbamazepine | 298-46-4 | sc-202518 sc-202518A | 1 g 5 g | $33.00 $71.00 | 5 | |
Initially developed as an anticonvulsant, carbamazepine also exhibits Nav1 inhibitory effects. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
A well-known local anesthetic, lidocaine acts as a reversible Nav1 inhibitor. It blocks sodium channels in sensory neurons, leading to the temporary loss of pain sensation. | ||||||
5,5-Diphenyl Hydantoin | 57-41-0 | sc-210385 | 5 g | $70.00 | ||
Primarily used as an antiepileptic drug, phenytoin also demonstrates Nav1 inhibitory properties. It stabilizes neuronal membranes by selectively binding to the inactive state of Nav1 channels, preventing their activation and reducing neuronal excitability. | ||||||
A 887826 | 1266212-81-0 | sc-362708 sc-362708A | 10 mg 50 mg | $215.00 $849.00 | ||
A-887826 is a selective Nav1.9 inhibitor. Nav1.9 channels are predominantly expressed in nociceptive neurons, and inhibition of these channels may reduce pain perception. | ||||||